These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 39127016)

  • 1. Cold atmospheric plasma enhances SLC7A11-mediated ferroptosis in non-small cell lung cancer by regulating PCAF mediated HOXB9 acetylation.
    Zhang C; Liu H; Li X; Xiao N; Chen H; Feng H; Li Y; Yang Y; Zhang R; Zhao X; Du Y; Bai L; Ma R; Wan J
    Redox Biol; 2024 Sep; 75():103299. PubMed ID: 39127016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PCAF-mediated acetylation of transcriptional factor HOXB9 suppresses lung adenocarcinoma progression by targeting oncogenic protein JMJD6.
    Wan J; Xu W; Zhan J; Ma J; Li X; Xie Y; Wang J; Zhu WG; Luo J; Zhang H
    Nucleic Acids Res; 2016 Dec; 44(22):10662-10675. PubMed ID: 27613418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of AlkB homolog 5 suppresses the progression of non-small cell lung cancer by facilitating ferroptosis through m6A demethylation of SLC7A11.
    Huang Z; Lin G; Hong Y; Weng L; Zhu K; Zhuang W
    Environ Toxicol; 2024 Jul; 39(7):4035-4046. PubMed ID: 38642004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LAPTM4B counteracts ferroptosis via suppressing the ubiquitin-proteasome degradation of SLC7A11 in non-small cell lung cancer.
    Yan R; Liu D; Guo H; Liu M; Lv D; Björkblom B; Wu M; Yu H; Leng H; Lu B; Li Y; Gao M; Blom T; Zhou K
    Cell Death Dis; 2024 Jun; 15(6):436. PubMed ID: 38902268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem Cell Factor SOX2 Confers Ferroptosis Resistance in Lung Cancer via Upregulation of SLC7A11.
    Wang X; Chen Y; Wang X; Tian H; Wang Y; Jin J; Shan Z; Liu Y; Cai Z; Tong X; Luan Y; Tan X; Luan B; Ge X; Ji H; Jiang X; Wang P
    Cancer Res; 2021 Oct; 81(20):5217-5229. PubMed ID: 34385181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzo(a)pyrene promotes the malignant progression of malignant-transformed BEAS-2B cells by regulating YTH N6-methyladenosine RNA binding protein 1 to inhibit ferroptosis.
    Wang N; Chen HQ; Zeng Y; Shi Y; Zhang Z; Li JY; Zhou SM; Li YW; Deng SW; Han X; Zhou ZY; Yao ML; Liu WB
    Toxicology; 2024 Sep; 507():153886. PubMed ID: 39002880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIM3 facilitates ferroptosis in non-small cell lung cancer through promoting SLC7A11/xCT K11-linked ubiquitination and degradation.
    Wang Z; Shen N; Wang Z; Yu L; Yang S; Wang Y; Liu Y; Han G; Zhang Q
    Cell Death Differ; 2024 Jan; 31(1):53-64. PubMed ID: 37978273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PART1 facilitates tumorigenesis and inhibits ferroptosis by regulating the miR-490-3p/SLC7A11 axis in hepatocellular carcinoma.
    Li D; Wan M; Liu X; Ojha SC; Sheng Y; Li Y; Sun C; Deng C
    Aging (Albany NY); 2024 Jul; 16(14):11339-11358. PubMed ID: 39029955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal lncRNA ROR1-AS1 from cancer-associated fibroblasts inhibits ferroptosis of lung cancer cells through the IGF2BP1/SLC7A11 signal axis.
    Yao F; Zhao Y; Wang G; Zhao M; Hong X; Ye Z; Dong F; Li W; Deng Q
    Cell Signal; 2024 Aug; 120():111221. PubMed ID: 38729321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing lncRNA SLC16A1-AS1 Induced Ferroptosis in Renal Cell Carcinoma Through miR-143-3p/SLC7A11 Signaling.
    Li YZ; Zhu HC; Du Y; Zhao HC; Wang L
    Technol Cancer Res Treat; 2022; 21():15330338221077803. PubMed ID: 35167383
    [No Abstract]   [Full Text] [Related]  

  • 11. CircPDSS1 (hsa_circ_0017998) silencing induces ferroptosis in non-small-cell lung cancer cells by modulating the miR-137/SLC7A11/GPX4/GCLC axis.
    Wu L; Li N; Zhu L; Shao G
    Toxicol In Vitro; 2024 Aug; 99():105887. PubMed ID: 38945378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLC7A11/ xCT is a target of miR-5096 and its restoration partially rescues miR-5096-mediated ferroptosis and anti-tumor effects in human breast cancer cells.
    Yadav P; Sharma P; Sundaram S; Venkatraman G; Bera AK; Karunagaran D
    Cancer Lett; 2021 Dec; 522():211-224. PubMed ID: 34571083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of DDR1 promotes ferroptosis and overcomes gefitinib resistance in non-small cell lung cancer.
    Zhang Y; Qian J; Fu Y; Wang Z; Hu W; Zhang J; Wang Y; Guo Y; Chen W; Zhang Y; Wang X; Xie Z; Ye H; Ye F; Zuo Z
    Biochim Biophys Acta Mol Basis Dis; 2024 Oct; 1870(7):167447. PubMed ID: 39089636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma.
    Liu L; He J; Sun G; Huang N; Bian Z; Xu C; Zhang Y; Cui Z; Xu W; Sun F; Zhuang C; Man Q; Gu S
    Clin Transl Med; 2022 May; 12(5):e778. PubMed ID: 35522946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HOXB9 enhances the ability of lung cancer cells to penetrate the blood-brain barrier.
    Zheng H; Li C; Li Z; Zhu K; Bao H; Xiong J; Liang P
    Aging (Albany NY); 2020 Dec; 13(4):4999-5019. PubMed ID: 33411683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Butyrate enhances erastin-induced ferroptosis of lung cancer cells via modulating the ATF3/SLC7A11 pathway.
    Bi R; Hu R; Jiang L; Wen B; Jiang Z; Liu H; Mei J
    Environ Toxicol; 2024 Feb; 39(2):529-538. PubMed ID: 37341073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The splicing factor SF3B1 confers ferroptosis resistance and promotes lung adenocarcinoma progression via upregulation of SLC7A11.
    Guo Y; Wang X; Du Y; Zhao Y; Gao L; Hao Y; Lv D; Feng X; Zhai Y; Zou B; Han J; Xu E; Yang Y; Yang B; Xi Y; Zhang L
    Cancer Gene Ther; 2024 Oct; 31(10):1498-1510. PubMed ID: 39127833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TCF12 induces ferroptosis by suppressing OTUB1-mediated SLC7A11 deubiquitination to promote cisplatin sensitivity in oral squamous cell carcinoma.
    Liu Y; Bai Q; Pang N; Xue J
    Cell Biol Int; 2024 Nov; 48(11):1649-1663. PubMed ID: 38946134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LPCAT2 inhibits colorectal cancer progression via the PRMT1/SLC7A11 axis.
    Cao N; Zhang F; Yin J; Zhang J; Bian X; Zheng G; Li N; Lin Y; Luo L
    Oncogene; 2024 May; 43(22):1714-1725. PubMed ID: 38605214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HSDL2 knockdown promotes the progression of cholangiocarcinoma by inhibiting ferroptosis through the P53/SLC7A11 axis.
    Ma S; Ma Y; Qi F; Lei J; Chen F; Sun W; Wang D; Zhou S; Liu Z; Lu Z; Zhang D
    World J Surg Oncol; 2023 Sep; 21(1):293. PubMed ID: 37718459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.